MedTrace Logo

Sleep for Stroke Management and Recovery Trial

NCT03812653 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3062

Last updated 2026-02-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.

Conditions

Interventions

DEVICE

CPAP

Automatically-adjusting continuous positive airway pressure (CPAP) delivered using a study supplied device.

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • FusionHealth LLC

    collaborator UNKNOWN

  • Medical University of South Carolina

    collaborator OTHER

  • University of Cincinnati

    collaborator OTHER

  • University of Michigan

    lead OTHER

Principal Investigators

  • Devin Brown, MD, MS · University of Michigan

  • Ronald Chervin, MD, MS · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2026-11-30
Completion
2026-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03812653 on ClinicalTrials.gov